The PANIC Study in brief

The Physical Activity and Nutrition in Children (PANIC) Study is a long-term lifestyle intervention and follow-up study of a population-based cohort of 504 children aged 7–9 years at baseline. The participants have been followed prospectively from childhood into adulthood, complemented by retrospective data extending back to fetal life. The study provides extensive multimodal, life-course data for investigating the development of health and risk factors for chronic diseases (ClinicalTrials.gov: NCT01803776; PANIC metadata on Zenodo).

The baseline examinations were conducted in mid-childhood in 2007–2009, followed by assessments in late childhood in 2009–2011, adolescence in 2015–2017, and early adulthood in 2024–2026. The early-adulthood follow-up also included the PANIC Fat Biopsy Study, in which subcutaneous adipose tissue samples were collected for advanced molecular analyses. The next follow-up is planned for 2028–2030, when participants will be 27–29 years of age.

At all four study phases, comprehensive assessments of lifestyle, growth, body composition, metabolic and cardiovascular health, and circulating biomarkers have been performed. Insulin resistance has been estimated using the homeostatic model assessment for insulin resistance (HOMA-IR), calculated from fasting plasma glucose and serum insulin concentrations. Glucose tolerance and insulin responses have additionally been assessed using a 2-hour oral glucose tolerance test in adolescence and early adulthood. Lipid metabolism has been characterized by measuring plasma total, LDL, and HDL cholesterol and triglyceride concentrations. These measurements have been complemented by extensive serum metabolomic profiling using liquid chromatography–mass spectrometry (LC-MS) and nuclear magnetic resonance (NMR) spectroscopy, as well as genome-wide genetic analyses. The early-adulthood follow-up further included magnetic resonance imaging (MRI) of abdominal adipose tissue and the liver, magnetic resonance spectroscopy (MRS) of liver fat, and subcutaneous adipose tissue biopsies for advanced multiomics analyses.

The PANIC Study is conducted at the Institute of Biomedicine, School of Medicine, University of Eastern Finland (UEF), in collaboration with researchers from other units of UEF, Kuopio University Hospital, and several national and international universities, hospitals, and research institutes. The Principal Investigator is Timo A. Lakka, MD, PhD, Professor of Medical Physiology, Specialist in Internal Medicine, and Adjunct Professor of Public Health (Connect; PubMed).

Research Aims:

The PANIC Study aims to investigate:

  1. Risk factors and pathophysiological mechanisms underlying chronic diseases and conditions—including obesity, type 2 diabetes, metabolic dysfunction-associated steatotic liver disease (MASLD), atherosclerotic cardiovascular disease, cognitive disorders, osteoporosis, mental health disorders, oral diseases, and chronic pain—from fetal life to adulthood.
  2. The effects of physical activity, diet, and other lifestyle factors on these diseases and conditions and their modifiable risk factors from childhood to adulthood.
  3. How genetic, developmental, and environmental factors modify the effects of physical activity, diet, and other lifestyle factors on these diseases and conditions and their modifiable risk factors across the life course.
  4. Factors influencing health care utilization and costs, and the cost-effectiveness of lifestyle interventions and other strategies for preventing chronic diseases and conditions.